Citius Oncology Inc

Research Citius Oncology Inc (CTOR) on Bullrun: market cap USD 64.28M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCTOR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 64.28M
• Financial periodFY2025
• Net income-USD 24.76M

Valuation Snapshot

latest market cap is USD 64.28M.

About Citius Oncology Inc

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.

Frequently asked questions

What is Citius Oncology Inc's market cap?

Citius Oncology Inc's market capitalization is USD 64.28M.

What does Citius Oncology Inc do?

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma.